Long Term Safety Study of Study Drug (Eszopiclone) in Children and Adolescents With ADHD -Associated Insomnia

Clinical trial NCT00857220 · COMPLETED

Trial details

NCT number: NCT00857220
Sponsor: Sumitomo Pharma America, Inc.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Insomnia Attention Deficit Hyperactivity Disorder

Start date: 2009-05-01
Primary completion: 2011-10-01
Enrollment: 304

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.